Garde Capital’s Alkermes ALKS Stock Holding History

Garde Capital’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10	Closed	-$287	–	266
2025 Q2	$287	Hold	10	–	–	﹤0.01%	765
2025 Q1	$331	Buy	+10	New	+$326	﹤0.01%	740

Other funds holding ALKS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Garde Capital's ALKS Position: Q3 2025 in Review

Garde Capital sold out of Alkermes (ALKS) in Q3 2025, closing a stake of 10 shares — an estimated $287 sold.

Garde Capital first reported a position in ALKS in Q1 2025 and held it in 2 quarters. The position peaked at $331 in Q1 2025. 358 funds tracked by Wall St. Rank hold ALKS as of Q3 2025.

Garde Capital reported no remaining Alkermes position as of Q3 2025 after selling out during the quarter.
Garde Capital sold 10 Alkermes shares in Q3 2025, an estimated $287.
Garde Capital first reported a position in Alkermes in Q1 2025 and held it in 2 quarters.
Garde Capital's Alkermes position peaked at $331 in Q1 2025.
358 funds tracked by Wall St. Rank held Alkermes as of Q3 2025.

Based on Garde Capital's 13F filing for Q3 2025, filed 16 Dec 2025.